RIDA®GENE Lac Intol
Intended use:For in-vitro diagnostic use. The RIDA®GENE Lac Intol test, which is performed on the LightCycler® 480 II, is a multiplex real-time PCR for the qualitative detection and [...]
we have started to provide the documents for our products in an electronic format. These are the Instructions for Use (IFU), the Safety Data Sheets (SDS) and the Certificate of Analysis (CoA). For batches placed on the market after 01 January 2023, you can find our documents on the eIFU portal https://eifu.r-biopharm.com.
Intended use:For in-vitro diagnostic use. The RIDA®GENE Lac Intol test, which is performed on the LightCycler® 480 II, is a multiplex real-time PCR for the qualitative detection and [...]
Intended use:For in vitro diagnostic use. The RIDA®GENE Pediatric Viral Panel test, performed on the LightCycler® 480 II real-time PCR instrument, is a multiplex real-time RT-PCR for the direct [...]
The new generation of the RIDA®GENE multiplex real-time PCR kits offers a number of improvements—and makes molecular laboratory diagnostics even more efficient and flexible.
Community-acquired pneumonia (CAP) is the most common fatal infectious disease in western countries. Bacteria are the most common pathogens causing CAP, where one differentiates between typical [...]
“Early and consistent tuberculosis detection to break infection chains and eliminate the disease worldwide” R-Biopharm has launched a new generation of diagnostics for the global [...]
Mississauga, Canada and Darmstadt, Germany, 15th May 2020 – R-Biopharm AG and Microbix Biosystems Inc. (TSX: MBX, Microbix®), a life sciences innovator, announces the appointment of R-Biopharm [...]